about
Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharideInterferon-alpha/beta receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006Alpha/beta and gamma interferons are induced by infection with noncytopathic bovine viral diarrhea virus in vivo.Interferon Alpha Treatment and Thyroid DysfunctionInterferon induced thyroiditis.Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis.Hepatitis C and interferon induced thyroiditis.Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft modelIFN-α mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms.T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease.The effects of pegylated interferon-α and ribavirin on liver and serum concentrations of activin-A and follistatin in normal Wistar rat: a preliminary reportTargeting interferon-alpha: a promising approach for systemic lupus erythematosus therapy.Pegylated Interferon-α Modulates Liver Concentrations of Activin-A and Its Related Proteins in Normal Wistar Rat.Src is required for migration, phagocytosis, and interferon beta production in Toll-like receptor-engaged macrophagesInteraction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.Opportunistic autoimmune disorders: from immunotherapy to immune dysregulationThe inducible nitric-oxide synthase (iNOS)/Src axis mediates Toll-like receptor 3 tyrosine 759 phosphorylation and enhances its signal transduction, leading to interferon-β synthesis in macrophages.Serum Activins and Follistatin during the Treatment of Chronic Hepatitis C Genotypes 1 and 4 and Their Correlations with Viral Load and Liver Enzymes: A Preliminary Report.Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy.Environmental triggers of thyroiditis: hepatitis C and interferon-α.Regulation of effector and memory T-cell functions by type I interferon.Type 1 Diabetes Mellitus Associated with Pegylated Interferon-α Plus Ribavirin Treatment for Chronic Hepatitis C: Case Report and Literature Review.Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis.Type I interferon protects mice from fatal neurotropic infection with Langat virus by systemic and local antiviral responses.Pre-assembly of STAT4 with the human IFN-alpha/beta receptor-2 subunit is mediated by the STAT4 N-domain.A prospective study of lymphocyte subpopulations and regulatory T cells in patients with chronic hepatitis C virus infection developing interferon-induced thyroiditis.Regulatory T cells and other lymphocyte subpopulations in patients with melanoma developing interferon-induced thyroiditis during high-dose interferon-α2b treatment.Potential Mechanisms Underlying Inflammation-Enhanced Aminoglycoside-Induced Cochleotoxicity.Dendrimers: Breaking the paradigm of current musculoskeletal autoimmune therapies.Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes.Characterization of Monocyte-Derived Dendritic Cells Maturated With IFN-alpha
P2860
Q24538617-E981803C-514E-465B-A2DD-47BB8866FCB6Q24794822-0F141232-7AE9-4E9F-A5EA-3B3D30AC5A72Q27472937-11B699ED-CB96-4451-8200-DE5A4A1B7AF2Q27483686-F8710573-A903-40C5-AB49-C38F2A60818BQ33636049-222CB578-EA04-4432-A541-A8D84C838E27Q33644094-EE7049CB-889E-4E0E-B05C-59897DB0E55DQ33716540-8B6B8154-DA07-4FBA-92C6-DBCAF2D198B0Q33767212-FC013124-B908-4EDE-A503-A57363AA53BFQ35020174-7F91DE1F-E188-4A0B-B1A2-A17432B09DC6Q35596780-1915B0AE-53C1-4336-840C-8387EAA7813FQ35674832-E2CF86F5-D540-4CA7-B70E-841E78709265Q35824498-69454E19-68C1-4B73-AAEC-5EC55E20C50AQ35864762-EC4F168C-A986-4FC2-B821-BB5112B02B4EQ37167073-0F58C1EA-7128-4ECE-B05A-D43FCD435F32Q37260388-BD183094-54EC-409B-8FEC-4F733F0460FBQ37274049-6C23CD8F-6D49-44AB-9C3C-8746D3409F36Q37691701-1C7D4714-FD45-4B0A-AFD5-8D234264654CQ37715878-D651AFEB-D33B-40B0-A01E-0B1676ECE911Q37729135-739DC4FE-C0CA-4F68-B7CC-5F159336C08FQ37836257-1DE0AF0F-3BBE-493B-A17F-48046C5F14A1Q37841676-03677CF8-D0F8-4ADF-A624-83CB2C53CB1DQ38033554-2E6FC609-3BE7-4347-8251-E9A5519B326BQ39130808-35C298B8-DBC5-4265-AA70-D3BE475093FFQ40196805-38DA4D54-4B40-43ED-BAAF-956836D48F76Q40210236-A63F2A63-AF49-4B8D-91DB-CFEE36AF3912Q45366434-3A0F942D-67A6-47AB-866F-BEB1F25CE76CQ45728702-BB92D39F-E56D-4646-AB63-5999E4981BF5Q47128203-9973D738-4CB1-49E0-A95F-0A142CF4B56CQ47429306-965F2F7A-3BA8-49E0-92AD-0C71AA169C37Q48791219-F4511354-BE2A-414C-9C5F-A62E5C1152AFQ56999847-ACECBC27-3BD0-409E-9DCD-4E4A7E91DC66
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Type I interferons and T helper development.
@ast
Type I interferons and T helper development.
@en
Type I interferons and T helper development.
@nl
type
label
Type I interferons and T helper development.
@ast
Type I interferons and T helper development.
@en
Type I interferons and T helper development.
@nl
prefLabel
Type I interferons and T helper development.
@ast
Type I interferons and T helper development.
@en
Type I interferons and T helper development.
@nl
P1433
P1476
Type I interferons and T helper development.
@en
P2093
P304
P356
10.1016/S0167-5699(00)01710-2
P577
2000-10-01T00:00:00Z